|
|
||||||||||||||
|
Research Interests
Drug Discovery and Medicinal Chemistry
The main focus of our research is the application of computer-aided drug design and synthetic chemistry to create new drug candidates for cancer, viral infections, and neurodegenerative diseases such as Alzheimer’s disease. Novel molecules are evaluated using a variety of biochemical, biophysical, and cell-based screening assays, as well as animal models of disease, both within our lab and in partnership with local and international collaborators. Consideration of drug-likeness is an integral part of our design process, since good ADMET properties are crucial for our molecules to reach the clinic.
Please note:Many of our projects are commercially sensitive and cannot be advertised on the web. Please contact Dr Ben Ross to discuss the Group's latest research projects. |
Latest News
2 April 2013: Welcome Mr Suresh Veliyath (PhD candidate). Suresh has a masters degree in pharmaceutical chemistry from Rajiv Gandhi University, Bangalore. He worked as a project assistant at the Indian Institute of Science (IISC) Bangalore and as a faculty member at MIPS Hyderabad, before joining the Ross Group. Suresh's PhD project is focused on AD drug discovery.
6 February 2013: Welcome Mr Girdhar Singh Deora (PhD candidate). Giri completed a MPharm from Rajiv Gandhi Technological University, Bhopal in 2009. Prior to joining the Ross Group, Giri worked as a research associate at Rajiv Gandhi Technological University (2010-11) and at Dr Reddy's Institute of Life Sciences, Hyderabad (2011-13). Giri's PhD project is in the field of AD drug discovery.
10 January 2013: Welcome Mr Edward Lee (PhD candidate). Eddy completed a BPharm (2010) and postgraduate honours (2012) degrees at UQ and he was awarded an APA scholarship for his PhD project to develop anti-viral nanoparticles.
1 November 2012: Welcome Mr Satish Dighe (PhD candidate). Satish was awarded an MPharm in 2009 from Pune University, and worked as a research chemist at Zydus-Cadila Healthcare Limited (2009-11; Ahmedabad) and as a research assistant at the Birla Institute of Techology and Science (2011-12; Pilani), before joining the Ross Group. The topic of Satish's PhD project is AD drug discovery.
3 July 2012: Welcome Mr Srinivas Kantham (PhD candidate) who is funded by a prestigious Prime Minister's Australia Asia Incoming Postgraduate Award. For his PhD Srinivas is developing polyphenols as disease-modifying drugs for AD. Previously he worked as a research assistant at the Indian Institute of Chemical Technology (IICT) Hyderabad.
|
Contact
Dr Ben Ross
Courier address: School of Pharmacy, The University of Queensland, 20 Cornwall Street, Woolloongabba, Qld 4102, Australia
Postal address: School of Pharmacy, The University of Queensland, Brisbane, Qld 4072, Australia
Phone: +61 7 334 61900 Fax: +61 7 334 61999
Email:
|
 |
This web site was last updated on 16 December 2015. Copyright © 2006-2016 Benjamin P. Ross. Unless stated otherwise, this web site represents only the views of Benjamin P. Ross and not the views of The University of Queensland. Simple site map. |
